Detail akcie TEVA PHARMACEUT.INDUSTR.SP-ADR online

Business Summary: Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Financial Summary: BRIEF: For the six months ended 30 June 2024, Teva Pharmaceutical Industries Ltd (ADR) revenues increased 6% to $7.98B. Net loss applicable to common stockholders decreased 10% to $985M. Revenues reflect United States segment increase from $1.68B to $3.84B, Europe segment increase of 6% to $2.49B, International Markets segment increase of 12% to $1.19B, United States segment increase from $1.68B to $3.84B.